Phantosmia: Phantom Smells in Aging & Neurological Disabilities

Phantosmia: Understanding Olfactory Hallucinations in Aging and Neurological Conditions

Imagine opening your front door and detecting the unmistakable smell of burning rubber - except there's nothing burning. Or perhaps you notice a foul odor of rotting food emanating from an empty kitchen. For people experiencing phantosmia, these sensations feel completely real, even though no actual odor source exists. Phantosmia, also known as olfactory hallucinations or phantom odors, is a puzzling neurological and medical phenomenon that disrupts the normal functioning of the olfactory system. While less commonly discussed than visual or auditory hallucinations, phantosmia presents significant challenges to quality of life and can serve as an important clinical indicator of underlying health conditions. This paper examines what phantosmia is, explores its causes and mechanisms, and investigates its particular significance for older adults and individuals living with neurological disabilities.

Main Content

What is Phantosmia?

Phantosmia is defined as the perception of an odor in the absence of any identifiable stimulus in the environment [4]. In other words, a person experiences a genuine sensory experience of a smell that isn't actually present. The condition differs from a related disorder called parosmia, in which real smells are perceived as distorted or changed. With phantosmia, there is simply no odor source to detect - the smell is generated internally by the olfactory system or brain.

The experience of phantosmia varies significantly from person to person. Some individuals report pleasant scents, such as flowers or baked goods, while others encounter distinctly unpleasant smells. The most commonly reported phantom odors include burning or burnt toast, tobacco smoke, rotting or spoiled food, ammonia, gasoline, fecal matter, and metallic odors [1]. These smells may appear in one nostril or both, and they may persist constantly or come and go throughout the day.

From a medical perspective, olfactory disorders like phantosmia are classified as either conductive or sensorineural. Conductive olfactory dysfunction involves an obstruction preventing odorants from reaching the olfactory receptors in the nasal cavity. Sensorineural dysfunction, which includes phantosmia, results from impaired transmission or processing of olfactory signals [4]. Researchers also categorize phantosmia using central and peripheral classifications. Peripheral phantosmia originates from disruption of the olfactory mucosa and sensory receptors, while central phantosmia arises from aberrant integration and interpretation of signals within the brain itself [4].

Prevalence of Phantosmia

Phantosmia accounts for approximately 10 to 20 percent of all olfactory complaints, making it a relatively uncommon condition [1,4]. However, its true prevalence is difficult to establish due to variations in how it's measured, differences in how people self-report symptoms, and inconsistencies in diagnostic standards. A survey of over 3,600 U.S. adults aged 40 and older found a phantosmia prevalence of approximately 6 percent [4]. A similar Swedish study of adults aged 60 and older reported a prevalence of 4.9 percent [11,12]. These numbers suggest that while not epidemic, phantosmia affects a meaningful segment of the adult population, particularly in midlife and beyond.

Causes and Underlying Mechanisms

The causes of phantosmia are diverse and multifactorial. The condition can originate from either peripheral issues affecting the nose and olfactory receptors or central nervous system problems affecting how the brain processes smell signals. Understanding these causes is crucial for treatment.

Common Medical and Environmental Causes

Many temporary and treatable conditions can trigger phantosmia. Upper respiratory infections, sinus infections, and allergies frequently cause phantom smells, as inflammation irritates the olfactory nerves [1,9]. Nasal polyps, congestion, and postnasal drip contribute to olfactory dysfunction. Dental problems, including gum disease, poor oral hygiene, and dry mouth, can also produce phantom odors [1]. Some individuals develop phantosmia following head trauma or injury to the olfactory pathways [2,5]. COVID-19 and other viral infections have been documented as triggers, particularly when they damage the olfactory system during the acute illness [1,8,9].

Certain medications alter smell perception, and exposure to toxic chemicals such as mercury, lead, or other environmental contaminants may induce phantom smells. Additionally, tobacco smoking and strong chemical irritants in the environment aggravate the olfactory system [1]. For some people, phantosmia appears after radiation therapy for cancer.

Neurological and Neuropsychiatric Causes

More serious neurological conditions can manifest as phantosmia. Temporal lobe seizures frequently trigger olfactory hallucinations, which may occur before, during, or after a seizure event [3]. Migraines, particularly those with auras, can produce phantom smells as a warning sign preceding the headache [11]. Head injury and traumatic brain injury may damage neural pathways involved in olfaction, leading to phantom odors [5].

Several neurodegenerative diseases are associated with phantosmia. Parkinson's disease patients experience olfactory dysfunction in 65 to 90 percent of cases, with phantosmia reported in varying frequencies ranging from 0.5 to 18.2 percent of Parkinson's patients [21,23,25]. The olfactory bulb - a brain region directly connected to the olfactory nerves - is among the earliest affected areas in Parkinson's disease [17]. Researchers theorize that hyperexcitable dopaminergic activity in the olfactory pathway, combined with denervation from the disease process, may generate phantom smells [26]. Alzheimer's disease also shows associations with phantosmia, though it appears less frequently than in Parkinson's disease, with baseline rates of 2 percent increasing to 4.4 percent during disease progression [21,23]. Dementia with Lewy bodies can present with olfactory hallucinations as an early or prominent symptom [24,29].

Stroke and intracranial hemorrhage can produce phantosmia through damage to brain regions processing olfactory information. Brain tumors and other intracranial masses may compress or irritate olfactory pathways. Psychiatric conditions, including schizophrenia, depression, anxiety disorders, and post-traumatic stress disorder, have been associated with olfactory hallucinations, though the precise mechanisms remain poorly understood [23].

Psychiatric and Psychological Factors

While less common as sole causes, severe stress, anxiety, and depression can sometimes trigger sensory distortions including phantom smells. Some research suggests that approximately 17 to 30 percent of patients with olfactory dysfunction experience depression [17], though it remains unclear whether the depression causes the olfactory dysfunction or results from it.

Phantosmia in Aging and Senior Populations

Older adults face particular vulnerability to phantosmia due to age-related changes in the olfactory system and the increased prevalence of conditions associated with phantom smells.

Age-Related Olfactory Changes

The sense of smell naturally declines with advancing age. Research indicates that olfactory dysfunction is present in 7.5 to 11 percent of healthy 60-year-olds and increases to approximately 35 percent by age 78 [19]. After the seventh decade of life, olfactory decline becomes considerably more pronounced [19]. These changes result from multiple factors: reduced airflow through the nasal passages, drier mucous membranes, diminished numbers of olfactory receptor cells, and reduced central processing capacity in the brain [18].

Interestingly, these age-related changes that reduce overall smell function can paradoxically increase the likelihood of phantom smells. When the olfactory system is compromised, it becomes more prone to generating false signals, resulting in the perception of odors that don't exist [18]. Additionally, older adults frequently experience multiple conditions simultaneously - infections, allergies, medication effects, and neurological changes - all of which can contribute to phantosmia.

Prevalence in Seniors

Population-based research specifically examining phantosmia in older adults reveals its significance in this age group. A Swedish study of 2,569 adults aged 60 to 90 found a prevalence of 4.9 percent, with the phenomenon associated with female gender, vascular risk burden, and distorted smell sensations [11,12]. Importantly, the study found that among older adults, phantosmia often occurred alongside parosmia (distorted smells), suggesting these conditions may share underlying mechanisms [11].

Impact on Quality of Life

For seniors, phantosmia can be particularly disruptive. Persistent unpleasant phantom odors may reduce appetite and interfere with eating, leading to nutritional deficits - a significant concern for older adults already at risk for malnutrition [9]. The unexpected and alarming nature of phantom smells, particularly those suggesting danger like burning or gas leaks, can trigger anxiety and disrupt sleep patterns [18]. Some seniors report that phantom smells evoke deep autobiographical memories or emotions, adding a psychological dimension to the experience [11]. The condition can erode quality of life if not properly managed, as older adults may withdraw from social situations or become preoccupied with the phantom odors [6].

Clinical Considerations for Seniors

Healthcare providers evaluating seniors for phantosmia must consider the complexity of conditions common in this population. Medications used to treat hypertension, diabetes, arthritis, and other chronic conditions can affect smell perception. Polypharmacy - the use of multiple medications simultaneously - increases the likelihood of medication-related phantosmia [13]. Age-related cognitive changes may also make it more difficult for seniors to accurately describe or distinguish phantom smells from real odors, complicating diagnosis.

Phantosmia and Neurological Disabilities

Phantosmia holds particular clinical significance as a symptom of neurological and neurodegenerative disabilities. Understanding these connections is crucial for early diagnosis and intervention.

Parkinson's Disease

Parkinson's disease represents one of the most prominent neurological conditions associated with olfactory dysfunction. While quantitative olfactory loss (hyposmia and anosmia) is the most frequently documented olfactory problem in Parkinson's disease, qualitative olfactory disturbances including phantosmia also occur [22,25]. The olfactory bulb, which directly receives signals from olfactory nerves, undergoes pathological changes early in Parkinson's disease, preceding motor symptom onset by several years [17].

The mechanisms underlying phantosmia in Parkinson's disease likely involve the neurochemical changes characteristic of the disease. Dopamine dysregulation and the selective loss of specific neural populations in the olfactory pathways may create an environment where false signals are generated. Some researchers propose that the combination of denervation (nerve loss) and compensatory hyperexcitability in remaining dopaminergic neurons produces phantom smells [26].

Clinically, olfactory testing, including assessment for phantosmia, may serve as an early biomarker for Parkinson's disease [17,19]. Less than one-quarter of individuals with olfactory dysfunction spontaneously report their symptoms, making systematic screening important [17,19]. For individuals with Parkinson's disease, phantosmia may indicate disease progression and warrant adjustment of treatment approaches.

Alzheimer's Disease and Other Dementias

Alzheimer's disease involves pathological changes in multiple brain regions, including those processing olfactory information. While olfactory deficits are common in Alzheimer's disease, occurring in 85 percent of early-stage cases, overt phantosmia appears less frequently [17,19]. However, when present, it warrants investigation. Some research suggests that olfactory risk factors and impairment may predict cognitive decline and dementia development [17].

Dementia with Lewy bodies presents a unique clinical picture regarding phantosmia. Case reports describe patients with dementia with Lewy bodies whose initial symptom was headache accompanied by olfactory hallucinations, preceding the typical visual and auditory hallucinations associated with this condition [24,29]. This suggests that phantosmia may be an underrecognized early manifestation of certain dementias, and clinicians should maintain appropriate suspicion when patients report new-onset phantom smells, particularly when accompanied by other neurological symptoms.

Epilepsy and Seizure Disorders

Temporal lobe epilepsy frequently produces olfactory auras - hallucinations that precede seizure activity [3]. These phantom smells typically last seconds to minutes and often consist of unpleasant odors. The temporal lobe contains regions critical for olfactory processing and emotional response, explaining why seizure activity in this region produces olfactory phenomena. For patients with known or suspected epilepsy, temporal relationship between phantom smells and other seizure symptoms can help localize seizure onset.

Other Neurological Conditions

Stroke and transient ischemic attack can produce olfactory hallucinations through disruption of vascular supply to olfactory pathways or brain regions processing smell. Brain tumors, particularly those affecting the temporal lobe or olfactory regions, may produce phantom smells as a presenting symptom. Multiple sclerosis, another neurological condition affecting disabled individuals, has been documented in association with phantosmia [24].

Implications for Disability and Functional Status

For individuals living with neurological disabilities, phantosmia represents more than just a bothersome symptom. In occupational contexts where a keen sense of smell is essential - such as cooking, perfumery, firefighting, or quality control positions - phantosmia may render work impossible or dangerous [6]. The symptom can interfere with daily activities, relationships, and self-care. Additionally, the presence of phantosmia alongside other neurological symptoms may indicate disease progression, necessitating medical evaluation and treatment adjustments.

Diagnosis and Evaluation

Healthcare providers evaluating phantosmia employ a systematic approach to identify underlying causes. A thorough history is essential, including detailed questioning about the specific odors perceived, their duration and frequency, whether they occur in one or both nostrils, and any temporal relationship to other symptoms or events [1,4].

Physical examination includes nasal inspection for signs of infection, inflammation, polyps, or structural abnormalities. A complete neurological examination may reveal signs suggesting central nervous system involvement. Healthcare providers assess whether the phantosmia occurs in isolation or alongside other symptoms like headaches, seizure activity, or cognitive changes.

When history and physical examination don't reveal an obvious cause, imaging studies become necessary. Nasal endoscopy allows direct visualization of the nasal passages and olfactory regions. Computed tomography or magnetic resonance imaging can assess for sinusitis, nasal polyps, masses, or structural abnormalities [1,4]. When central causes are suspected, brain imaging may reveal tumors, stroke, or other intracranial pathology. Electroencephalography (EEG) helps identify seizure disorders [1].

Olfactory testing using validated instruments like the University of Pennsylvania Smell Identification Test (UPSIT) or Scandinavian Odor Identification Test (SOIT) can quantify overall olfactory function, though these tests are less useful for specifically identifying phantosmia [4]. However, they provide context about overall olfactory status and may reveal coexisting olfactory deficits.

Treatment and Management

Treatment of phantosmia depends on identifying and addressing the underlying cause. When phantosmia results from acute conditions like colds, infections, or allergies, the phantom smells typically resolve as the underlying condition improves [1,4].

Peripheral Causes

For phantosmia arising from peripheral causes, treatment focuses on improving olfactory mucosa function. Some studies have examined local anesthetic application to the olfactory mucosa, though such treatments typically provide only temporary relief. Surgical resection of the olfactory mucosa has produced long-lasting symptom relief in small patient populations [4]. Treatment of underlying nasal disease, including sinusitis and nasal polyps, often reduces or eliminates phantom smells [4].

Central Causes

When phantosmia originates from neurological or psychiatric conditions, treatment targets the underlying disorder. Patients with migraine-associated phantosmia often experience symptom resolution with appropriate migraine prophylaxis [4]. Seizure disorders require anticonvulsant medications, which frequently resolve olfactory hallucinations. Medications used to treat depression and anxiety can also alleviate phantosmia in some patients.

Psychotropic medications including antipsychotics and antidepressants show promise in treating some cases of phantosmia, particularly when psychiatric conditions are involved [4]. Individual case reports describe symptom resolution with specific antidepressants even in patients without primary psychiatric diagnoses, suggesting broader neurochemical mechanisms.

Transcranial magnetic stimulation has shown effectiveness in providing short-term relief, though long-term benefits remain limited [4]. In cases where root cause-directed treatment is pursued, approximately 73 percent of patients experience long-lasting symptom relief, compared to only 32 percent of patients managed with observation alone [4].

General Management Strategies

For patients with persistent phantosmia without identified treatable causes, practical strategies include avoiding known triggers such as smoking, strong chemical exposures, and environmental irritants [1]. Medication review by healthcare providers may identify agents contributing to phantom smells, allowing for potential substitution or dosage adjustment. Saline nasal irrigation can improve nasal air flow and reduce irritation [18].

Given the documented association between olfactory dysfunction and depression, mental health support is appropriate for individuals experiencing significant distress from phantosmia [17]. Stress reduction techniques and cognitive behavioral approaches may help patients cope with persistent symptoms.

Conclusion

Phantosmia represents a fascinating and clinically important intersection of sensory neurobiology, aging, and neurological disease. While relatively uncommon, affecting perhaps 4 to 6 percent of the population, its impact on individual quality of life can be substantial, particularly for older adults and those living with neurological disabilities. The condition can emerge from diverse causes ranging from simple sinus infections to serious brain tumors and progressive neurodegenerative diseases, necessitating careful clinical evaluation. For seniors experiencing age-related changes in smell coupled with multiple medical conditions and medications, the development of phantom smells warrants medical attention rather than dismissal. For individuals with Parkinson's disease, dementia, epilepsy, or other neurological disabilities, phantosmia may represent an important clinical marker deserving systematic assessment. As research continues to illuminate the mechanisms of olfactory hallucinations and the connections between smell disorders and neurological diseases, healthcare providers and patients alike will be better equipped to recognize, investigate, and manage this intriguing but often overlooked condition. Understanding phantosmia contributes not only to improved symptom management but also to earlier diagnosis of serious underlying conditions and ultimately to better health outcomes and quality of life for affected individuals.

References

[1] Cleveland Clinic. (2023). Phantosmia (Olfactory Hallucinations): Causes & Treatment.

[2] Mayo Clinic. (2024). Phantosmia: What causes olfactory hallucinations?

[3] Wikipedia. (2025). Phantosmia.

[4] StatPearls. (2023). Phantosmia. NCBI Bookshelf.

[5] Hancock Health. (2025). Phantosmia: What causes olfactory hallucinations?

[6] Apollo Hospitals. (2024). Phantosmia: Causes, Diagnosis and Treatment.

[7] Medical News Today. (2023). Phantosmia: Symptoms, Causes, Diagnosis, Treatment.

[8] Beacon Health System. (2024). Phantosmia: What causes olfactory hallucinations?

[9] Apollo 247. (2024). Understanding Phantosmia: Symptoms and Causes.

[10] MyMLC. (2024). Phantosmia: What causes olfactory hallucinations?

[11] Sjölund, S., Larsson, M., Olofsson, J.K., Seubert, J., & Laukka, E.J. (2017). Phantom Smells: Prevalence and Correlates in a Population-Based Sample of Older Adults. Chemical Senses, 42(4), 309-318.

[12] Oxford Academic. (2017). Phantom Smells: Prevalence and Correlates in a Population-Based Sample of Older Adults. Chemical Senses.

[13] AgingCare.com. (2020). Loss of Smell in the Elderly.

[14] ScienceDirect. (2021). Olfactory dysfunction in aging and neurodegenerative diseases.

[15] Nature. (2022). Olfactory distortions in the general population. Scientific Reports.

[16] PMC. (2024). Phantosmia in Parkinson's Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations.

[17] PMC. (2020). Olfactory dysfunction in aging and neurodegenerative diseases.

[18] Neufutur. (2025). Phantom Odors (Phantosmia) in Seniors and Why They Happen.

[19] PMC. (2021). Olfactory dysfunction in aging and neurodegenerative diseases.

[20] ScienceDirect Topics. (2024). Phantosmia – an overview.

[21] MDPI. (2023). Phantosmia in Parkinson's Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations.

[22] JAMA Network. (2008). Phantosmias and Parkinson Disease.

[23] MDPI. (2023). Phantosmia in Parkinson's Disease: A Systematic Review.

[24] The Journal of Neuropsychiatry and Clinical Neurosciences. (2021). Headache-Associated Phantosmia as a Harbinger of Lewy Body Dementia.

[25] PMC. (2021). Frequency and Determinants of Olfactory Hallucinations in Parkinson's Disease Patients.

[26] ResearchGate. (2008). Phantosmias and Parkinson Disease.

[27] ResearchGate. (2009). Parkinsonism: The Hyposmia and Phantosmia Connection.

Insights, Analysis, and Developments

Author Credentials: Ian is the founder and Editor-in-Chief of Disabled World, a leading resource for news and information on disability issues. With a global perspective shaped by years of travel and lived experience, Ian is a committed proponent of the Social Model of Disability-a transformative framework developed by disabled activists in the 1970s that emphasizes dismantling societal barriers rather than focusing solely on individual impairments. His work reflects a deep commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.